Department of Integral Paediatric Dentistry, University Dental Clinic, University of Murcia, Hospital Morales Meseguer, 2a planta, C/ Marqués de los Vélez, s/n., 30007, Murcia, Spain.
Department of Orthodontics, Faculty of Medicine, University of Murcia, Murcia, Spain.
Clin Oral Investig. 2020 Mar;24(3):1287-1297. doi: 10.1007/s00784-019-03007-7. Epub 2019 Jul 16.
Hypomineralised second primary molars (HSPM) are due to idiopathic hypomineralisation that affects from 1- to 4-s primary molars, and its aetiology remains unclear. Our objective was to systematically review studies in which the investigators had studied the association between HSPM and drug use during pregnancy and the first year of life.
A systematic search for publications until July 2018 was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) statement. No restrictions were placed on year of publication. The PECO Question was as follows: P, children exposed to drugs during pregnancy and the first year of life; E, drugs to which mothers, during pregnancy and their offspring were exposed; C, control groups from studies with the same characteristics not exposed to drugs during pregnancy and the first year of life; and O, relationship between drug exposure during pregnancy and the first year of life and HSPM. Two reviewers extracted the data and assessed the risk of bias using the Newcastle-Ottawa Scale criteria.
We initially identified 986 articles, or which seven were selected for review: two case-control studies, one cross-sectional studies and four cohort studies. Four studies reported data on drug consumption during pregnancy and four investigated drug use during the first year of life and the occurrence of enamel defects in primary dentition.
There is no clear evidence that the use of drugs during pregnancy and during the first year of life is associated with HSPM. Further well-designed prospective studies are needed.
Determining the etiological factors related to the development of HSPM would help to establish preventive protocols in patients at potential risk. As HSPM is predictive of molar incisor hypomineralisation (MIH), the application of preventive protocols would avoid complications in both the primary and permanent dentition.
低矿化第二恒磨牙(HSPM)是由特发性低矿化引起的,影响 1-4 岁的乳磨牙,其病因尚不清楚。我们的目的是系统地回顾研究中,研究人员研究了 HSPM 与妊娠和生命第一年使用药物之间的关系。
根据系统评价和荟萃分析的首选报告项目(PRISMA)声明,对截至 2018 年 7 月的出版物进行了系统搜索。对出版物的年份没有限制。PECO 问题如下:P,妊娠和生命第一年暴露于药物的儿童;E,母亲在妊娠期间及其后代暴露的药物;C,来自具有相同特征且未在妊娠和生命第一年暴露于药物的研究的对照组;O,妊娠期间暴露于药物与 HSPM 之间的关系。两位审阅者提取数据并使用纽卡斯尔-渥太华量表标准评估偏倚风险。
我们最初确定了 986 篇文章,其中有 7 篇被选入审查:2 项病例对照研究,1 项横断面研究和 4 项队列研究。四项研究报告了妊娠期间药物消耗的数据,四项研究调查了生命第一年药物使用和乳牙釉质缺陷的发生。
没有明确的证据表明妊娠期间和生命第一年使用药物与 HSPM 有关。需要进一步进行设计良好的前瞻性研究。
确定与 HSPM 发展相关的病因因素将有助于为有潜在风险的患者建立预防方案。由于 HSPM 是磨牙切牙低矿化症(MIH)的预测因子,因此预防方案的应用将避免乳牙和恒牙的并发症。